Moreover, the emergence of innovative markers such as ctDNA has offered promising approaches to address the diagnostic challenges of CCA, revealing that TP53 and KRAS are among the genes with the highest frequency of mutations. The gene discussed is TP53; the disease is cholangiocarcinoma.